Guardian Pharmacy Services, Inc. (GRDN) research
Guardian Pharmacy Services, Inc.- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $44.16
- As of
Guardian Pharmacy Services, Inc. (GRDN): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-10.
As of . Source: SEC EDGAR filings for GRDN. Method and limitations.
Share the GRDN intelligence card
See GRDN live in the terminal
Track GRDN's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live GRDN terminal, freeActive signals for GRDN
- highCONSENSUS_SELL
3 tracked funds reduced GRDN this 2026Q2, institutional consensus
- highCONSENSUS_SELL
3 tracked funds reduced GRDN this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +344% to GRDN (2026Q2)
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 55% of GRDN (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 87% of GRDN (2026Q2)
FREE, NO ACCOUNT
Every signal on GRDN, as it fires
You are seeing 5 of 24 signals recorded on GRDN since 2026-05-30.
The five above landed across 2 days. The other 19 were recorded on 3 other days. 15 of the 24 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in GRDN (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 40145W101 · 2026Q2 | $5M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 40145W101 · 2026Q2 | $4.1M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 40145W101 · 2026Q2 | $3.7M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 40145W101 · 2026Q2 | $3.1M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 40145W101 · 2026Q2 | $1.9M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, GRDN
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
GRDN against its peers
GRDN's operating margin of 5.0% ranks in the 56th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | GRDN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.4B USD | 1.4B USD | 58 | 17 |
| Gross margin | 20.2% | n/a | n/a | 4 |
| Operating margin | 5.0% | 2.1% | 56 | 16 |
| Net margin | 3.4% | 1.4% | 55 | 18 |
| Return on equity | 22.6% | 8.3% | 91 | 15 |
| P / E | n/a | 24.4x | n/a | 10 |
Peers (18): NHC, ADUS, CON, SNDA, ASTH, LFST, SGRY, AGL, INNV, ARDT, NUTX, FMS, TOI, SRTA, MCTA, CYH, AIRS, JYNT. Left out: BUHPY (no annual filing), LTGHY (no annual filing), GMRS (no annual filing), AUNA (no annual filing), FSNUY (no annual filing), HWAIF (no annual filing), WW (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (GRDN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more GRDN signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GRDNand get the insider, 13F, options, and confluence read in one view.